Annovis Bio Inc (ANVS) Implied Volatility Current

Tracking ANVS implied volatility helps you identify when options premiums on Annovis Bio Inc are historically cheap or expensive, and where the best trades are hiding. Annovis Bio Inc implied volatility reflects the market's expectation of future price movement: when ANVS IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Annovis Bio Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ANVS, tracking metrics like ANVS IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ANVS signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia.

The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ANVS implied volatility sits today versus where it has been. Our scanner ranks Annovis Bio Inc implied volatility against its historical range, surfaces extremes in ANVS IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Annovis Bio Inc IV is rich or cheap — measure it, then act on it.